Find your next paid study

Stanford UniversityNCT03868150

~$25 – $1,000

Actual pay is set by the research site.

Hepatocellular Carcinoma (HCC)

A Phase 1/2 Study of Tegavivint Plus Zanzalintinib in Patients With Advanced Hepatocellular Carcinoma

The goal of this clinical trial is to evaluate the combination of zanzalintinib (XL092) and tegavivint in advanced hepatocellular carcinoma (HCC) and Wnt pathw…

University of Texas Southwestern Medical CenterNCT07878689

~$150 – $3,000

Actual pay is set by the research site.

Advanced Kidney CarcinomaAdvanced Renal Cell CarcinomaHereditary Leiomyomatosis and Renal Cell Carcinoma+6 more

Mercaptopurine (6-MP) for the Treatment of Manifestations of Hereditary Leiomyomatosis and Renal Cell Carcinoma (HLRCC)

This phase I/II trial studies the side effects and best dose of mercaptopurine, and to see how well it works in treating patients with hereditary leiomyomatosi…

Jonsson Comprehensive Cancer CenterNCT07716735

~$150 – $3,000

Actual pay is set by the research site.

Opioid-use DisorderChronic Pain

Optimization of Non-Invasive Brain Stimulation for Treatment of Addiction

The purpose of this study is to assess the effects of transcranial Direct Current Stimulation (tDCS) applied in conjunction with Transcranial Ultrasound (TUS) …

Case Western Reserve UniversityNCT04379115

Actual pay is set by the research site.

Spinal Cord InjuryAmyotrophic Lateral SclerosisBrain Stem Infarctions+2 more

Enhancement and Optimization of a Mobile iBCI for Veterans With Paralysis

VA research has been advancing a high-performance brain-computer interface (BCI) to improve independence for Veterans and others living with tetraplegia or the…

VA Office of Research and DevelopmentNCT05470478

~$10 – $675

Actual pay is set by the research site.

Stroke PatientsCPAPOSA - Obstructive Sleep Apnea

Optimizing Adherence to the Treatment of Sleep Apnea Among Patients With Stroke Undergoing Inpatient Rehabilitation

The SCOUTS 3 study aims to test the effectiveness of an intensive CPAP (Continuous Positive Airway Pressure) therapy support program compared to usual care in …

University of WashingtonNCT06722755

Actual pay is set by the research site.

Neurometabolic Profile of Individuals With Primary Mitochondrial Disease

Primary Mitochondrial Disease (PMD) is a genetic neurometabolic disorder, leading to central nervous system degeneration and increased risk of early mortality.…

Primary Mitochondrial Disease

Children's Hospital of PhiladelphiaNCT06890520

Actual pay is set by the research site.

Ovarian CancerMelanomaTriple Negative Breast Cancer+1 more

A Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics/Pharmacodynamics, and Antitumor Activity of NM1F as Monotherapy and in Combination With Pembrolizumab in Subjects With Locally Advanced/Metastatic Solid Tumors

A Phase 1 Study to Investigate the Safety, Tolerability, Pharmacokinetics/Pharmacodynamics, and Antitumor Activity of NM1F as Monotherapy and in Combination wi…

Hefei TG ImmunoPharma Co., Ltd.NCT05746897

~$150 – $4,200

Actual pay is set by the research site.

Advanced Solid Malignancies

A First-in-Human, Open-Label, Phase 1/2 Dose-Escalation With Enrichment and Dose-Expansion Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of GIM-122 as a Single Agent in Adult Subjects With Advanced Solid Malignancies

GIM-122 is a first-in-class, humanized immunoglobulin G1 kappa dual functioning monoclonal antibody (DFA). This phase 1 / 2 study plans to evaluate the safety,…

Georgiamune IncNCT06028074

~$150 – $4,200

Actual pay is set by the research site.

GVHD - Graft-Versus-Host Disease

A Phase I-II Study of High-Dose Post-Transplant Cyclophosphamide, Bortezomib, and Abatacept for the Prevention of Graft-versus-Host Disease (GvHD) Following Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)

Phase I-II studying post transplant cyclophosphamide, bortezomib and sitagliptin for GvHD prevention in allogeneic HSCT. Adults with hematologic malignancies u…

Northwell HealthNCT07675174

~$150 – $4,500

Actual pay is set by the research site.

A Multi-Center Randomized Clinical Study of the NOCISCAN MR Spectroscopy (MRS) in Patients Treated for Discogenic Low Back Pain

This study is looking into how useful NOCISCAN is. NOCISCAN is a software as a Service (SaaS) tool that uses Magnetic Resonance (MR) spectroscopy. Nociscan lev…

Low Back Pain

~$10 – $1,125

Actual pay is set by the research site.

AclarionNCT06661850

Glucagon Response in Patients With Type 1 Diabetes Mellitus Following a Very Low Carbohydrate

Despite major technological advances, management of type one diabetes mellitus (T1D) remains suboptimal, putting millions of people at risk for immediate and l…

Type1diabetes